Global investment firm backs growth plans for TTP Labtech Cambridge, UK: TTP Labtech Ltd, an international leader in the design and development of automated instrumentation and consumables for life science research is pleased to announce that investment from Battery Ventures has underpinned their aggressive growth plans. Over the last 18 years TTP Labtech has successfully […]
New enterprise brings together cutting-edge technologies in Genetic Testing from Ambry, Konica Minolta’s Imaging, and AI-technology from Invicro, to fight diseases including cancer and Alzheimer’s Offering fully-fledged precision medicine services to pharmaceutical companies, academia and medical institutions/hospitals in Japan Tokyo – Konica Minolta, Inc. (“Konica Minolta”) (TOKYO: 4902; ISIN: JP3300600008) today announced the launch of […]
On September 26, 2018, BGI and Maxwell Plus executed a collaborative research project “A model to predict the risk of developing advanced or metastatic prostate cancer using genetic makeup and family history of cancers”. Prostate cancer is the second most common type of cancer among males in Western countries, with an estimated 165,000 new cases and 29,500 […]
STONY BROOK N.Y. – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) announced today that it is launching an additional system to tag the industry’s larger volume cannabis or hemp grows as part of TheraCann International’s ETCH Biotrace™ solution. On the heels of its successful showing of its first Cannabis Tagging System (CTS) in July […]
Probes for CGI’s FISH-based HPV-Associated Cancer Test (FHACT®) test to be manufactured by Agilent RUTHERFORD, N.J. — Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today announced that it has signed a non-exclusive supply agreement with Agilent Technologies Inc. through which Agilent will […]
Important research collaboration for pioneering PRS approach to help drug developers running clinical trials identify and stratify between slow and rapid progressors of the disease Oxford & Manchester, UK. Cytox, a precision medicine company which today is commercializing polygenic risk scoring (PRS) approaches for assessing genetic risk for developing Alzheimer’s and other neurological diseases, has announced […]
First-to-market cell line-derived reference standard for myeloid blood cancers Largest cell-line derived reference standard available, contains 22 mutations across 19 oncology-relevant genes Enables faster, more reliable and more cost-effective assay validation Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the […]
HAYWARD, Calif.–Mawi DNA Technologies, a biotechnology company focusing on the development of innovative technologies for biosampling, announces the launch of iSWAB-Cells. Designed to collect and stabilize intact cells for up to four weeks at room temperature, the sample collection system enables researchers to perform multiple OMICS analyses from the same sample. The iSWAB-Cells family of […]
Next Generation Sequencing (NGS) Kit to Improve Speed and Accuracy of M. Tuberculosis (MTB) Drug Sensitivity Testing (DST) at a Fraction of the Current Cost of Sequencing BETHESDA, Md. — Longhorn Vaccines and Diagnostics LLC (LHNVD), a private pre-analytical systems and molecular solutions company, is pleased to announce the validation of its newest technology, PrimeSeqMDR™, across a […]
Durham – North Carolina, USA: SOPHiA GENETICS, leader in Data-Driven Medicine, today announced from the Personalized Medicine World Congress (PMWC) at Duke University that the company has opened operations in Boston to meet the burgeoning demand across the United States. SOPHiA AI (SOPHiA) is the most widely used technology for genomic analysis, adopted by hundreds […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
